Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells

被引:184
|
作者
Kato, K
Cantwell, MJ
Sharma, S
Kipps, TJ
机构
[1] Univ Calif San Diego, Sch Med, Dept Med, Div Hematol Oncol, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Sch Med, Human Gene Therapy Program, La Jolla, CA 92093 USA
来源
JOURNAL OF CLINICAL INVESTIGATION | 1998年 / 101卷 / 05期
关键词
CD40-ligand; leukemia; antigen presentation; immune activation; gene therapy;
D O I
10.1172/JCI1472
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
CD40-CD40-ligand (CD154) interactions play a critical role in immune activation, Using replication defective adenovirus encoding mouse CD154 (Ad-CD154), we modified human chronic lymphocytic leukemia B cells to express a functional ligand for CD40. This not only induces expression of immune accessory molecules on the infected cell, but also allows it to trans-activate noninfected bystander leukemia B cells, Also, factors that impair the antigen-presenting capacity of leukemia B cells are downmodulated. Ad-CD154-infected leukemia cells are highly effective stimulators in mixed lymphocyte reactions and can induce generation of cytotoxic T lymphocytes specific for autologous nonmodified leukemia cells, As such, Ad-CD154 can induce a host antileukemia response that may have therapeutic potential.
引用
收藏
页码:1133 / 1141
页数:9
相关论文
共 50 条
  • [21] Regulation of apoptosis by CD40-ligand in malignant B-cells
    Dallman, C
    Johnson, P
    Packham, G
    BRITISH JOURNAL OF CANCER, 2001, 85 : 59 - 59
  • [22] Gene transfer of the CD40-ligand to human dendritic cells induces NK-mediated antitumor effects against human carcinoma cells
    Tomihara, Kei
    Kato, Kazunori
    Masuta, Yukari
    Nakamura, Kiminori
    Tanaka, Toshihiro
    Hiratsuka, Hiroyoshi
    Hamada, Hirofumi
    INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (07) : 1491 - 1498
  • [23] B29 gene transfer into chronic lymphocytic leukemia B cells
    Gordon, MS
    Fluckiger, AC
    Rawlings, DJ
    Thompson, AA
    Wall, R
    FASEB JOURNAL, 1998, 12 (05): : A1082 - A1082
  • [24] IL-13 INDUCES PROLIFERATION AND DIFFERENTIATION OF HUMAN B-CELLS ACTIVATED BY THE CD40-LIGAND
    COCKS, BG
    MALEFYT, RD
    GALIZZI, JP
    DEVRIES, JE
    AVERSA, G
    INTERNATIONAL IMMUNOLOGY, 1993, 5 (06) : 657 - 663
  • [25] STUDY OF CD40 LIGAND EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
    BRUGNONI, D
    ROSSI, G
    TUCCI, A
    CATTANEO, R
    AIRO, P
    HAEMATOLOGICA, 1995, 80 (05) : 440 - 442
  • [26] Acquired CD40 ligand deficiency in patients with B cell chronic lymphocytic leukemia.
    Cantwell, MJ
    Hua, T
    Pappas, J
    Kipps, TJ
    BLOOD, 1996, 88 (10) : 1173 - 1173
  • [27] Induction of myeloid leukemia-derived antigen presenting cells by retinoid and CD40-ligand
    Masuta, Y
    Kato, K
    Tomihara, K
    Takahashi, S
    Hamada, H
    CANCER GENE THERAPY, 2003, 10 : S39 - S40
  • [28] Post-transcriptional regulation of CD40-ligand by CLL B cells.
    Cantwell, MJ
    Hua, T
    Kipps, TJ
    BLOOD, 1997, 90 (10) : 2617 - 2617
  • [29] Gene transfer of CD40-ligand to human dendritic cells induces growth arrest and apoptosis of tumor cells mediated by up-regulated TRAIL and its receptors.
    Tomihara, K
    Kato, K
    Masuta, Y
    Noguchi, M
    Hiratsuka, H
    Hamada, H
    BLOOD, 2004, 104 (11) : 941A - 941A
  • [30] Fas-ligand (CD178) and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells
    Dicker, F
    Kater, AP
    Fukuda, T
    Kipps, TJ
    BLOOD, 2005, 105 (08) : 3193 - 3198